Carbapenem- and colistin-resistant Enterobacter cloacae from Delta, Colorado, in 2015

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 5, 2016, Pages 3141-3144

  Norgan, Andrew P ^a   Freese, Jarred M ^b   Tuin, Patricia M ^b   Cunningham, Scott A ^c   Jeraldo, Patricio R ^c   Patel, Robin ^c  

^a Department of Laboratory Medicine and Pathology ^*  (United States)

^b Delta County Memorial Hospital   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; COLISTIN;

COLORADO; DRUG EFFECTS; ENTEROBACTER CLOACAE; GRAM NEGATIVE BACTERIUM; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE;

CARBAPENEMS; COLISTIN; COLORADO; DRUG RESISTANCE, MULTIPLE; ENTEROBACTER CLOACAE; GRAM-NEGATIVE BACTERIA; MICROBIAL SENSITIVITY TESTS;

EID: 84964909238     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03055-15     Document Type: Article

References (45)

1. Naas T, Nordmann P. 1994. Analysis of a carbapenem-hydrolyzing class A β-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. Proc Natl Acad Sci U S A 91:7693-7697. http://dx.doi.org/10.1073/pnas.91.16.7693.
2. Ambler RP. 1980. The structure of β-lactamases. Phil Trans R Soc Lond B Biol Sci 289:321-331. http://dx.doi.org/10.1098/rstb.1980.0049.
3. Pottumarthy S, Moland ES, Juretschko S, Swanzy SR, Thomson KS, Fritsche TR. 2003. NmcA carbapenem-hydrolyzing enzyme in Enterobacter cloacae in North America. Emerg Infect Dis 9:999-1002. http://dx.doi.org/10.3201/eid0908.030096.
4. Walther-Rasmussen J, Høiby N. 2007. Class A carbapenemases. J Antimicrob Chemother 60:470-482. http://dx.doi.org/10.1093/jac/dkm226.
5. Rasmussen BA, Bush K, Keeney D, Yang Y, Hare R, O'Gara C, Medeiros AA. 1996. Characterization of IMI-1 β-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob Agents Chemother 40:2080-2086.
6. Queenan AM, Bush K. 2007. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 20:440-458. http://dx.doi.org/10.1128/CMR.00001-07.
7. IMI-2 in an Enterobacter cloacae clinical isolate from China. Antimicrob Agents Chemother 50:1610-1611. http://dx.doi.org/10.1128/AAC.50.4.1610-1611.2006.
8. IMI-1 in an Enterobacter cloacae clinical isolate from France. Antimicrob Agents Chemother 56:1664-1665. http://dx.doi.org/10.1128/AAC.06328-11.
9. Österblad M, Kirveskari J, Hakanen AJ, Tissari P, Vaara M, Jalava J. 2012. Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11). J Antimicrob Chemother 67:2860-2864. http://dx.doi.org/10.1093/jac/dks299.
10. Teo JWP, La M-V, Krishnan P, Ang B, Jureen R, Lin RTP. 2013. Enterobacter cloacae producing an uncommon class A carbapenemase, IMI-1, from Singapore. J Med Microbiol 62:1086-1088. http://dx.doi.org/10.1099/jmm.0.053363-0.
11. Boo TW, O'Connell N, Power L, O'Connor M, King J, McGrath E, Hill R, Hopkins KL, Woodford N. 2013. First report of IMI-1-producing colistin-resistant Enterobacter clinical isolate in Ireland, March 2013. Euro Surveillance 18:pii=20548. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20548.
12. Huang L, Wang X, Feng Y, Xie Y, Xie L, Zong Z. 2015. First identification of an IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae in China. Ann Clin Microbiol Antimicrob 14:51. http://dx.doi.org/10.1186/s12941-015-0112-2.
13. Olaitan AO, Morand S, Rolain J-M. 2014. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol 5:643. http://dx.doi.org/10.3389/fmicb.2014.00643.
14. Liu Y-Y, Wang Y, Walsh TR, Yi L-X, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, Yu L-F, Gu D, Ren H, Chen X, Lv L, He D, Zhou H, Liang Z, Liu J-H, Shen J. 2016. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16:161-168. http://dx.doi.org/10.1016/S1473-3099(15)00424-7.
15. NDM) in Gram-negative bacilli. J Clin Microbiol 51:1269-1271. http://dx.doi.org/10.1128/JCM.03062-12.
16. IMP) in gram-negative rods resistant to broadspectrum beta-lactams. J Clin Microbiol 34:2909-2913.
17. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC. 2001. Novel carbapenem-hydrolyzingβ-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151-1161. http://dx.doi.org/10.1128/AAC.45.4.1151-1161.2001.
18. Queenan AM, Torres-Viera C, Gold HS, Carmeli Y, Eliopoulos GM, Moellering RC, Jr, Quinn JP, Hindler J, Medeiros AA, Bush K. 2000. SME-type carbapenem-hydrolyzing class A β-lactamases from geographically diverse Serratia marcescens strains. Antimicrob Agents Chemother 44:3035-3039. http://dx.doi.org/10.1128/AAC.44.11.3035-3039.2000.
19. Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, Nordmann P. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallobeta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 44:891-897. http://dx.doi.org/10.1128/AAC.44.4.891-897.2000.
20. European Committee on Antimicrobial Susceptibility Testing. 2015. Breakpoint tables for interpretation of MICs and zone diameters, version 5.0. European Committee on Antimicrobial Susceptibility Testing, Växjö, Sweden. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Breakpoint-tables/v-5.0-Breakpoint-Table-01.pdf.
21. Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114-2120. http://dx.doi.org/10.1093/bioinformatics/btu170.
22. Nurk S, Bankevich A, Antipov D, Gurevich AA, Korobeynikov A, Lapidus A, Prjibelski AD, Pyshkin A, Sirotkin A, Sirotkin Y, Stepanauskas R, Clingenpeel SR, Woyke T, Mclean JS, Lasken R, Tesler G, Alekseyev MA, Pevzner PA. 2013. Assembling single-cell genomes and mini-metagenomes from chimeric MDA products. J Comput Biol 20: 714-737. http://dx.doi.org/10.1089/cmb.2013.0084.
23. Eddy SR. 2011. Accelerated profile HMM searches. PLoS Comput Biol 7:e1002195. http://dx.doi.org/10.1371/journal.pcbi.1002195.
24. Gibson MK, Forsberg KJ, Dantas G. 2015. Improved annotation of antibiotic resistance determinants reveals microbial resistomes cluster by ecology. ISME J 9:207-216. http://dx.doi.org/10.1038/ismej.2014.106.
25. Zankari E, Hasman H, Kaas RS, Seyfarth AM, Agerso Y, Lund O, Larsen MV, Aarestrup FM. 2013. Genotyping using whole-genome sequencing is a realistic alternative to surveillance based on phenotypic antimicrobial susceptibility testing. J Antimicrob Chemother 68:771-777. http://dx.doi.org/10.1093/jac/dks496.
26. Lahiri SD, Johnstone MR, Ross PL, McLaughlin RE, Olivier NB, Alm RA. 2014. Avibactam and class C β-lactamases: mechanism of inhibition, conservation of the binding pocket, and implications for resistance. Antimicrob Agents Chemother 58:5704-5713. http://dx.doi.org/10.1128/AAC.03057-14.
27. Karageorgopoulos DE, Wang R, Yu X-H, Falagas ME. 2012. Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. J Antimicrob Chemother 67: 255-268. http://dx.doi.org/10.1093/jac/dkr466.
28. Reynolds R, Kidney A, Mushtaq S, BSAC Working Party on Resistance Surveillance. 2013. Surprisingly high prevalence of colistin-resistance in Enterobacter spp. in the UK and Ireland, abstr P1311. 23rd Eur Cong Clin Microbiol Infect Dis (ECCMID), 27 to 30 April 2013, Berlin, Germany.
29. Walkty A, DeCorby M, Nichol K, Karlowsky JA, Hoban DJ, Zhanel GG. 2009. In vitro activity of colistin (polymyxin E) against 3,480 isolates of Gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study, 2007-2008. Antimicrob Agents Chemother 53:4924-4926. http://dx.doi.org/10.1128/AAC.00786-09.
30. Thiolas A, Bollet C, La Scola B, Raoult D, Pagès J-M. 2005. Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient. Antimicrob Agents Chemother 49:1354-1358. http://dx.doi.org/10.1128/AAC.49.4.1354-1358.2005.
31. Aubron C, Poirel L, Ash RJ, Nordmann P. 2005. Carbapenemase producing Enterobacteriaceae, U.S. rivers. Emerg Infect Dis 11:260-264. http://dx.doi.org/10.3201/eid1102.030684.
32. Napier BA, Band V, Burd EM, Weiss DS. 2014. Colistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme. Antimicrob Agents Chemother 58:5594-5597. http://dx.doi.org/10.1128/AAC.02432-14.
33. Lesho E, Yoon E-J, McGann P, Snesrud E, Kwak Y, Milillo M, Onmus-Leone F, Preston L, St Clair K, Nikolich M, Viscount H, Wortmann G, Zapor M, Grillot-Courvalin C, Courvalin P, Clifford R, Waterman PE. 2013. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections. J Infect Dis 208:1142-1151. http://dx.doi.org/10.1093/infdis/jit293.
34. Telke AA, Rolain J-M. 2015. Functional genomics to discover antibiotic resistance genes: the paradigm of resistance to colistin mediated by ethanolamine phosphotransferase in Shewanella algae MARS14. Int J Antimicrobial Agents 46:648-652. http://dx.doi.org/10.1016/j.ijantimicag.2015.09.001.
35. Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, Ramphal R, Wagener MM, Miyashiro DK, Yu VL. 1991. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 115:585-590. http://dx.doi.org/10.7326/0003-4819-115-8-585.
36. Dubus A, Ledent P, Lamotte-Brasseur J, Frère JM. 1996. The roles of residues Tyr150, Glu272, and His314 in class C β-lactamases. Proteins 25:473-485.
37. Naas T, Massuard S, Garnier F, Nordmann P. 2001. AmpD is required for regulation of expression of NmcA, a carbapenem-hydrolyzing β-lactamase of Enterobacter cloacae. Antimicrob Agents Chemother 45:2908-2915. http://dx.doi.org/10.1128/AAC.45.10.2908-2915.2001.
38. Ehrhardt AF, Sanders CC, Romero JR, Leser JS. 1996. Sequencing and analysis of four new Enterobacter ampD alleles. Antimicrob Agents Chemother 40:1953-1956.
39. Kaneko K, Okamoto R, Nakano R, Kawakami S, Inoue M. 2005. Gene mutations responsible for overexpression of AmpC β-lactamase in some clinical isolates of Enterobacter cloacae. J Clin Microbiol 43:2955-2958. http://dx.doi.org/10.1128/JCM.43.6.2955-2958.2005.
40. Stapleton P, Shannon K, Phillips I. 1995. DNA sequence differences of ampD mutants of Citrobacter freundii. Antimicrob Agents Chemother 39: 2494-2498. http://dx.doi.org/10.1128/AAC.39.11.2494.
41. Bagge N, Ciofu O, Hentzer M, Campbell JIA, Givskov M, Høiby N. 2002. Constitutive high expression of chromosomal β-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD. Antimicrob Agents Chemother 46:3406-3411. http://dx.doi.org/10.1128/AAC.46.11.3406-3411.2002.
42. Kaase M, Szabados F, Anders A, Gatermann SG. 2014. Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany. J Clin Microbiol 52:1893-1897. http://dx.doi.org/10.1128/JCM.03484-13.
43. Lu CL, Liu CY, Huang YT, Liao CH, Teng LJ, Turnidge JD, Hsueh PR. 2011. Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods. Antimicrob Agents Chemother 55:4295-4301. http://dx.doi.org/10.1128/AAC.00349-11.
44. Stock I, Grüger T, Wiedemann B. 2001. Natural antibiotic susceptibility of strains of the Enterobacter cloacae complex. Int J Antimicrob Agents 18:537-545. http://dx.doi.org/10.1016/S0924-8579(01)00463-0.
45. Michalopoulos AS, Livaditis IG, Gougoutas V. 2011. The revival of fosfomycin. Int J Infect Dis 15:e732-e739. http://dx.doi.org/10.1016/j.ijid.2011.07.007.